Try GOLD - Free
"Evolving regulatory requirements, heightened scrutiny from regulatory agencies, and geopolitical uncertainties pose challenges"
Bio Spectrum
|BioSpectrum India May 2025
Strides Pharma Science demerged its Contract Development and Manufacturing Organisation (CDMO) business into OneSource Specialty Pharma Ltd, following approval by the National Company Law Tribunal (NCLT) in 2024.
-
OneSource Specialty Pharma, was listed on January 22, 2025 on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). With a revenue generation of around Rs 1500 crore during FY 2024-25, the company is providing seamless end-to-end offerings across all verticals (biologics, drug-device combinations, sterile injectables and Softgel capsules). In an interaction with BioSpectrum India, Neeraj Sharma, CEO & Managing Director, OneSource Specialty Pharma, upbeat about the growth of the CDMO sector, reveals more about the company's major focus areas in the coming years. Edited excerpts:
What have been the major highlights for this fiscal, and what are your upcoming plans?
This fiscal has been marked by significant milestones, namely the successful merger of the three incoming businesses, fundraising with participation from marquee investors, successful listing on the NSE and the BSE and significant addition to our customer base. The listing of OneSource Pharma on the NSE and BSE this year, marks a significant milestone in our journey, one that began with a vision to build a one-stop shop for the CDMO sector. Listing will increase our visibility among partners and stakeholders, opening up more opportunities for strategic collaborations and business ventures. It will also support the recruitment of talent from around the globe. The group is known for its strong corporate governance. We now have over 60 customers across all modalities and now we collaborate with 20 customers in the GLP-1 space. We have initiated our first new biological entity (NBE) programme with the top three animal health companies. Additionally, we are supporting seven potential new chemical entity (NCE)-1 programmes.
This story is from the BioSpectrum India May 2025 edition of Bio Spectrum.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Bio Spectrum
Bio Spectrum
Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing
Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.
1 min
May 2026
Bio Spectrum
NATHEALTH names Dr Sangita Reddy as new President
NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.
1 min
May 2026
Bio Spectrum
Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap
In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.
7 mins
May 2026
Bio Spectrum
WHO lays focus on simulation exercises to strengthen health emergency readiness
To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).
1 min
May 2026
Bio Spectrum
Akrivia Biosciences decodes breast cancer genomic heterogeneity
Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.
1 min
May 2026
Bio Spectrum
Integrating AI for Tech-driven Ayurveda
A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.
2 mins
May 2026
Bio Spectrum
ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation
ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.
1 min
May 2026
Bio Spectrum
MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students
MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.
1 min
May 2026
Bio Spectrum
Thermo Fisher launches integrated platform to accelerate biologics development
Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.
1 min
May 2026
Bio Spectrum
Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay
Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.
1 min
May 2026
Listen
Translate
Change font size